Bruce LJ, Beckmann R, Ribeiro ML, et al.A band 3based macrocomplex of integral and peripheral proteins in the RBC membrane. Blood 2003; 101:4180-8.10.1182/blood-2002-09-282412531814
Kroviarski Y, El Nemer W, Gane P, et al. Direct interaction between the Lu/B-CAM adhesion glycoproteins and er ythroid spectrin. Br J Haematol 2004;126:255-64.10.1111/j.1365-2141.2004.05010.x15238148
An X, Guo X, Sum H, et al. Phosphatidylserine binding sites in erythroid spectrin: location and implications for membrane stability. Biochemistry 2004;43:310-5.10.1021/bi035653h14717584
Mouro-Chanteloup I, Delaunay J, Gane P, et al. Evidence that the red cell skeleton protein 4.2 interacts with the Rh membrane complex member CD47. Blood 2003;101:338-44.10.1182/blood-2002-04-128512393467
Nicolas V, Le Van KC, Gane P, et al. Rh-RhAG/ankyrin-R, a new interaction site between the membrane bilayer and the red cell skeleton, is impaired by Rh(null)-associated mutation. J Biol Chem 2003;278:25526-33.10.1074/jbc.M302816200
Inaba M,Yawata A, Koshino I,et al. Defective anion transport and marked spherocytosis with membrane instability caused by hereditary total deficiency of red cell band 3 in cattle due to a nonsense mutation. J Clin Invest 1996;97:1804-17.10.1172/JCI118610
Ribeiro ML, Alloisio N, Almeida H, et al. Severe hereditary spherocytosis and distal renal tubular acidosis associated with the total absence of band 3. Blood 2000;96:1602-4.
Southgate CD, Chishti AH, Mitchell B, et al. Targeted disruption of the murine erythroid band 3 gene results in spherocytosis and severe haemolytic anaemia despite a normal membrane skeleton. Nat Genet 1996;14:227-30.10.1038/ng1096-227
Groves JD, Tanner MJ. The effects of glycophorin A on the expression of the human red cell anion transporter (band 3) in Xenopus oocytes. J Membr Biol 1994;140:81-8.
Bruce LJ, Groves JD, Okubo Y, et al. Altered band 3 structure and function in glycophorin A- and B-deficient (MkMk) RBCs. Blood 1994;84:916-22.10.1182/blood.V84.3.916.916
Bruce LJ, Pan RJ, Cope DL, et al. Altered structure and anion transport properties of band 3 (AE1, SLC4A1) in human red cells lacking glycophorin A.J Biol Chem 2004;279:2414-20.10.1074/jbc.M309826200
Wrong O, Bruce LJ, Unwin RJ, et al. Band 3 mutations, distal renal tubular acidosis, and Southeast Asian ovalocytosis. Kidney Int 2002; 62:10-9.10.1046/j.1523-1755.2002.00417.x
Tanner MJ. Band 3 anion exchanger and its involvement in erythrocyte and kidney disorders. Curr Opin Hematol 2002;9:133-9.10.1097/00062752-200203000-00009
Eber S, Lux SE. Hereditary spherocytosis—defects in proteins that connect the membrane skeleton to the lipid bilayer. Semin Hematol 2004;41:118-41.10.1053/j.seminhematol.2004.01.00215071790
Huang CH. Molecular insights into the Rh protein family and associated antigens. Curr Opin Hematol 1997;4:94-103.10.1097/00062752-199704020-000049107525
Cartron JP. RH blood group system and molecular basis of Rh-deficiency. Baillieres Best Pract Res Clin Haematol 1999;12:655-89.10.1053/beha.1999.004710895258
Beckmann R, Smythe JS,Anstee DJ,et al. Functional cell surface expression of band 3, the human RBC anion exchange protein (AE1), in K562 erythroleukemia cells: band 3 enhances the cell surface reactivity of Rh antigens. Blood 1998;92:4428-38.10.1182/blood.V92.11.4428
Beckmann R, Smythe JS, Anstee DJ, et al. Coexpression of band 3 mutants and Rh polypeptides: differential effects of band 3 on the expression of the Rh complex containing D polypeptide and the Rh complex containing CcEe polypeptide. Blood 2001;97:2496-505.10.1182/blood.V97.8.2496
Dahl KN, Westhoff CM, Discher DE. Fractional attachment of CD47 (IAP) to the erythrocyte cytoskeleton and visual colocalization with Rh protein complexes. Blood 2003;101:1194-9.10.1182/blood-2002-04-118712393442
Dahl KN, Parthasarathy R, Westhoff CM, et al. Protein 4.2 is critical to CD47-membrane skeleton attachment in human red cells. Blood 2004; 103:1131-6.10.1182/blood-2003-04-133114551146
Bruce LJ, Ghosh S, King MJ, et al. Absence of CD47 in protein 4.2-deficient hereditary spherocytosis in man: an interaction between the Rh complex and the band 3 complex. Blood 2002;100:1878-85.10.1182/blood-2002-03-070612176912
Huang CH, Liu PZ. New insights into the Rh superfamily of genes and proteins in erythroid cells and nonerythroid tissues. Blood Cells Mol Dis 2001;27:90-101.10.1006/bcmd.2000.035511358367
Marini AM, Matassi G, Raynal V, et al. The human rhesus-associated RhAG protein and a kidney homologue promote ammonium transport in yeast. Nat Genet 2000;26:341-4.10.1038/8165611062476
Westhoff CM, Ferreri-Jacobia M, Mak DO, et al. Identification of the erythrocyte Rh blood group glycoprotein as a mammalian ammonium transporter.J Biol Chem 2002;277:12499-502.10.1074/jbc.C200060200
Soupene E, King N, Feild E, et al. Rhesus expression in a green alga is regulated by CO(2). Proc Natl Acad Sci U S A 2002;99:7769-73.10.1073/pnas.112225599
Smith BL, Preston GM, Spring FA, et al. Human red cell aquaporin CHIP I. Molecular characterization of ABH and Colton blood group antigens. J Clin Invest 1994;94:1043-9.10.1172/JCI1174182951597521882
King LS, Kozono D, Agre P. From structure to disease: the evolving tale of aquaporin biology. Nature Reviews Molecular Cell Biology 2004; 5:687-98.10.1038/nrm1469
Roudier N, Ripoche P, Gane P, et al. AQP3 deficiency in humans and the molecular basis of a novel blood group system, GIL. J Biol Chem 2002;277:45854-9.10.1074/jbc.M208999200
Olives B, Neau P, Bailly P, et al. Cloning and functional expression of a urea transporter from human bone marrow cells. J Biol Chem 1994; 269:31649-52.10.1016/S0021-9258(18)31744-7
Edwards-Moulds J, Kasschau MR. Methods for the detection of Jk heterozygotes: interpretations and applications. Transfusion 1988;28:545-8.10.1046/j.1537-2995.1988.28689059028.x
Frohlich O,Macey RI, Edwards-Moulds J, et al. Urea transport deficiency in Jk(a–b–) erythrocytes. Am J Physiol 1991;260:C778-C783.10.1152/ajpcell.1991.260.4.C778
Macey RI,Yousef LW. Osmotic stability of red cells in renal circulation requires rapid urea transport. Am J Physiol 1988;254:C669-C674.10.1152/ajpcell.1988.254.5.C669
Miller LH, Mason SJ, Clyde DF,et al. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med 1976; 295:302-4.10.1056/NEJM197608052950602
Horuk R, Chitnis CE, Darbonne WC, et al. A receptor for the malarial parasite Plasmodium vivax: the er ythrocyte chemokine receptor. Science 1993;261:1182-4.10.1126/science.7689250
Chaudhuri A, Zbrzezna V, Polyakova J, et al. Expression of the Duffy antigen in K562 cells. Evidence that it is the human er ythrocyte chemokine receptor. J Biol Chem 1994;269: 7835-8.10.1016/S0021-9258(17)37123-5
Neote K,Mak JY,Kolakowski LF Jr., et al. Functional and biochemical analysis of the cloned Duffy antigen: identity with the RBC chemokine receptor. Blood 1994;84:44-52.10.1182/blood.V84.1.44.44
Yamada A, Kubo K, Takeshita T, et al. Molecular cloning of a glycosylphosphatidylinositol-anchored molecule CDw108. J Immunol 1999; 162:4094-100.10.4049/jimmunol.162.7.4094
Telen MJ. RBC surface adhesion molecules: their possible roles in normal human physiology and disease. Semin Hematol 2000;37:130-42.10.1016/S0037-1963(00)90038-6
Parsons SF, Spring FA, Chasis JA,et al. Erythroid cell adhesion molecules Lutheran and LW in health and disease. Baillieres Best Pract Res Clin Haematol 1999;12:729-45.10.1053/beha.1999.005010895261
Udani M, Zen Q, Cottman M, et al. Basal cell adhesion molecule/lutheran protein. The receptor critical for sickle cell adhesion to laminin. J Clin Invest 1998;101:2550-8.10.1172/JCI12045088449616226
Zen Q, Batchvarova M, Twyman CA, et al. B-CAM/LU expression and the role of B-CAM/LU activation in binding of low- and high-density red cells to laminin in sickle cell disease. Am J Hematol 2004;75:63-72.10.1002/ajh.1044214755370
Lee G, Spring FA, Parsons SF, et al. Novel secreted isoform of adhesion molecule ICAM-4: potential regulator of membrane-associated ICAM-4 interactions. Blood 2003;101:1790-7.10.1182/blood-2002-08-252912406883
Hermand P, Gane P, Huet M, et al. Red cell ICAM-4 is a novel ligand for platelet-activated alpha IIbbeta 3 integrin. J Biol Chem 2003;278:4892-8.10.1074/jbc.M21128220012477717
Lee S, Lin M, Mele A, et al. Proteolytic processing of big endothelin-3 by the Kell blood group protein. Blood 1999;94:1440-50.10.1182/blood.V94.4.1440
Vaughan JI, Manning M, Warwick RM, et al. Inhibition of erythroid progenitor cells by antiKell antibodies in fetal alloimmune anemia. N Engl J Med 1998;338:798-803.10.1056/NEJM1998031933812049504940
Southcott MJ,Tanner MJ, Anstee DJ.The expression of human blood group antigens during erythropoiesis in a cell culture system. Blood 1999;93: 4425-35.10.1182/blood.V93.12.4425
Bony V, Gane P, Bailly P, et al. Time-course expression of polypeptides carrying blood group antigens during human erythroid differentiation. Br J Haematol 1999;107:263-74.10.1046/j.1365-2141.1999.01721.x10583211
Yazdanbakhsh K, Lee S,Yu Q, et al. Identification of a defect in the intracellular trafficking of a Kell blood group variant. Blood 1999;94:310-8.10.1182/blood.V94.1.310.413k12_310_318
Spring FA, Gardner B, Anstee DJ. Evidence that the antigens of the Yt blood group system are located on human erythrocyte acetylcholinesterase. Blood 1992;80:2136-41.10.1182/blood.V80.8.2136.2136
Rao N, Whitsett CF, Oxendine SM, et al. Human erythrocyte acetylcholinesterase bears the Yta blood group antigen and is reduced or absent in the Yt(a–b–) phenotype. Blood 1993;81:815-9.10.1182/blood.V81.3.815.815
Rotundo RL. Expression and localization of acetylcholinesterase at the neuromuscular junction. J Neurocytol 2003;32:743-66.10.1023/B:NEUR.0000020621.58197.d4
Oxendine SM, Telen MJ, Rao N, et al. The Cartwright negative phenotype: an acquired phenomenon associated with anti-Ytab-like antibody.Transfusion 32[8S], 19S. 1992.
Rao N, Ferguson DJ, Lee SF, et al. Identification of human erythrocyte blood group antigens on the C3b/C4b receptor. J Immunol 1991;146:3502-7.10.4049/jimmunol.146.10.3502
Moulds JM, Nickells MW, Moulds JJ, et al. The C3b/C4b receptor is recognized by the Knops, McCoy, Swain-Langley, and York blood group antisera. J Exp Med 1991;173:1159-63.10.1084/jem.173.5.115921188661708809
Moulds JM, Zimmerman PA, Doumbo OK, et al. Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1. Blood 2001;97: 2879-85.10.1182/blood.V97.9.287911313284
Krych-Goldberg M, Atkinson JP. Structure-function relationships of complement receptor type 1. Immunol Rev 2001;180:112-22.10.1034/j.1600-065X.2001.1800110.x
Cockburn IA, Mackinnon MJ, O’Donnell A, et al. A human complement receptor 1 polymorphism that reduces Plasmodium falciparum rosetting confers protection against severe malaria. Proc Natl Acad Sci U S A 2004;101:272-7.10.1073/pnas.030530610131417514694201
Spring FA, Judson PA, Daniels GL, et al. A human cell-surface glycoprotein that carries Cromer-related blood group antigens on erythrocytes and is also expressed on leucocytes and platelets. Immunology 1987;62:307-13.
Telen MJ, Hall SE, Green AM, et al. Identification of human erythrocyte blood group antigens on decay-accelerating factor (DAF) and an erythrocyte phenotype negative for DAF. J Exp Med 1988;167:1993-8.10.1084/jem.167.6.199321896702455016
Holmes CH, Simpson KL, Wainwright SD, et al. Preferential expression of the complement regulatory protein decay accelerating factor at the fetomaternal interface during human pregnancy. J Immunol 1990;144:3099-105.10.4049/jimmunol.144.8.3099
Nowicki B, Hart A, Coyne KE, et al. Short consensus repeat-3 domain of recombinant decayaccelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of a cellcell interaction. J Exp Med 1993;178:2115-21.10.1084/jem.178.6.211521912837504058
Yu CY, Belt KT, Giles CM, et al. Structural basis of the polymorphism of human complement components C4A and C4B: gene size, reactivity and antigenicity. EMBO J 1986;5:2873-81.10.1002/j.1460-2075.1986.tb04582.x11672372431902
Blanchong CA, Chung EK, Rupert KL, et al. Genetic, structural and functional diversities of human complement components C4A and C4B and their mouse homologues, Slp and C4. Int Immunopharmacol 2001;1:365-92.10.1016/S1567-5769(01)00019-4
Tippett P, Storry JR,Walker PS,et al.Glycophorin A-deficient red cells may have a weak expression of C4-bound Ch and Rg antigens. Immunohematology 1996;12:4-7.10.21307/immunohematology-2019-737
Glinsky GV, Ivanova AB, Welsh J, et al. The role of blood group antigens in malignant progression, apoptosis resistance, and metastatic behavior. Transfus Med Rev 2000;14:326-50.10.1053/tmrv.2000.1623011055077
Garratty G. Blood group antigens as tumor markers, parasitic/bacterial/viral receptors, and their association with immunologically important proteins. Immunol Invest 1995;24:213-32.10.3109/088201395090627747713584